Provided by Tiger Fintech (Singapore) Pte. Ltd.

Telomir Pharmaceuticals

1.21
-0.0593-4.67%
Volume:192.46K
Turnover:236.14K
Market Cap:36.03M
PE:-2.92
High:1.29
Open:1.29
Low:1.19
Close:1.27
Loading ...

Telomir Pharmaceuticals Reports Positive Preclinical Data

TIPRANKS
·
18 Jun

Telomir Pharmaceuticals Inc - Telomir-1 Significantly Increased Cell Viability - SEC Filing

THOMSON REUTERS
·
18 Jun

Telomir Pharmaceuticals Reveals Promising Preclinical Data for Telomir-1 in Combatting Rapid Aging in Progeria Patients

Reuters
·
18 Jun

Telomir Pharmaceuticals Announces Promising Preclinical Results

TIPRANKS
·
11 Jun

Telomir Pharmaceuticals Inc - Telomir-1 Advancing Toward Ind Submission by Year-End - SEC Filing

THOMSON REUTERS
·
11 Jun

Telomir Pharmaceuticals: Telomir-1 Shows Dose-Dependent Restoration of Neurological, Liver & Kidney Function in Wilson’s Disease Animal Model

THOMSON REUTERS
·
11 Jun

Telomir Pharmaceuticals Unveils Promising Preclinical Results for Telomir-1 in Treating Wilson's Disease

Reuters
·
11 Jun

Telomir Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership: Alan Weichselbaum, Chief Financial Officer

Reuters
·
10 Jun

Telomir Pharmaceuticals-New Data From Preclinical Study of Its Lead Compound, Telomir-1, in Validated Animal Model of Werner Syndrome

THOMSON REUTERS
·
05 Jun

Telomir Pharmaceuticals- Announces Telomir-1 Resets Epigenetic Clock, Reverses DNA Methylation - SEC Filing

THOMSON REUTERS
·
05 Jun

Telomir Pharmaceuticals Unveils Promising Preclinical Study Results of Telomir-1 Showing Potential to Reverse Aging Effects in Werner Syndrome Model

Reuters
·
05 Jun

Telomir Pharmaceuticals Announces Upcoming Clinical Trials for Telomir-1, Aiming to Tackle Aging and Rare Diseases

Reuters
·
02 Jun

Telomir Pharmaceuticals Announces Promising Preclinical Results for Telomir-1 in Treating Age-Related Macular Degeneration

Reuters
·
29 May

BRIEF-Telomir Pharmaceuticals Inc - Michelle Yanez Steps Down As CFO Of Telomir Pharmaceuticals - SEC Filing

Reuters
·
22 May

Telomir Pharmaceuticals Appoints New Chief Financial Officer

TIPRANKS
·
22 May

Telomir Pharmaceuticals Inc - Appoints Alan Weichselbaum as CFO - SEC Filing

THOMSON REUTERS
·
22 May

Telomir Pharmaceuticals Obtains $3 Million in Straight Equity Sale

MT Newswires Live
·
21 May

Telomir Pharmaceuticals announces $3M in equity financing

TIPRANKS
·
21 May

Telomir Pharmaceuticals Secures $3M Equity Financing Boost

TIPRANKS
·
21 May

Telomir Pharmaceuticals Secures $3M Through Equity Sale at Premium, Following Prior $1M Investment

Reuters
·
21 May